Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: A pilot study

Rheumatology International

Volumn 26, Issue 3, 2006, Pages 252-256

  Strunk, Johannes ^a   Bundke, Elisabeth ^a   Lange, Uwe ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Rheumatoid arthritis; Vascular endothelial growth factor

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; INFLIXIMAB; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMAGING; MALE; PILOT STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PILOT PROJECTS; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 29244480303     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0619-5     Document Type: Article

References (27)

1. Schrieber L, Jackson JC (2004) Angiogenesis in Rheumatoid Arthritis. In: Klippel HJ, Dieppe PA (eds) Rheumatology, 2nd edn, vol 1. Mosby International, London, England, pp 12.1-12.4
2. Koch AE (1998) Angiogenesis - implications for rheumatoid arthritis. Arthritis Rheum 41(6):951-962
3. Jain A, Nanchahal J, Troeberg L, Green P, Brennan F (2001) Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. Arthritis Rheum 44(8):1754-1760
4. Koch AE, Volin MV, Woods JM, Kunkel SL, Connors MA, Harlow LA, Woodruff DC, Burdick MD, Strieter RM (2001) Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint. Arthritis Rheum 44(1):31-40
5. Paleolog EM (1996) Angiogenesis: a critical process in the pathogenesis of RA - a role of VEGF?. Br J Rheumatol 35:917-919
6. Afuwape AO, Kiriakidis S, Paleolog EM (2002) The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol Histopathol 17(3):961-972
7. Nagashima M, Yoshino S, Ishiwata T, Asano G (1995) Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 22:1624-1630
8. Kasama T, Shiozawa F, Kobayashi K, Yajima N, Hanyuda M, Takeuchi HT, Mori Y, Negishi M, Ide H, Adachi M (2001) Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis. Arthritis Rheum 44(11):2512-2524
9. Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, Ariyoshi M, Saiki T, Sakamoto M, Nagata K, Sata M, Matsuo K, Tanikawa K (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27:377-380
10. Wauke K, Nagashima M, Ishiwata T, Asano G, Yoshino S (2002) Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J Rheumatol 29(1):34-38
11. Latour F, Zabraniecki L, Dromer C, Brouchet A, Durroux R, Fournie B (2001) Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological and pathological study in 12 patients monitored for 10 years. Joint Bone Spine 68(6):493-498
12. Ballara S, Taylor PC, Reusch P, Marme D, Feldmann M, Maini RN, Paleolog EM (2001) Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum 44(9):2055-2064
13. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini R (1998) Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41(7):1258-1265
14. Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N (2003) Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 48(6):1521-1529
15. Ha IS, Um EY, Jung HR, Park HW, Cheong HI, Choi Y (2002) Glucocorticoid diminishes vascular endothelial growth factor and exacerbates proteinuria in rats with mesangial proliferative glomerulonephritis. Am J Kidney Dis 39(5):1001-1010
16. Pinheiro GR, Andrade CA, Gayer CR, Coelho MS, Freire SM, Scheinberg MA (2001) Serum vascular endothelial growth factor in late rheumatoid arthritis. Clin Exp Rheumatol 19(6):721-723
17. Kompella UB, Bandi N, Ayalasomayajula SP (2003) Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophtalmol Vis Sci 44(3):1192-1201
18. Edelman JL, Castro MR, Wen Y (1999) Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophtalmol Vis Sci 40(6):1112-1123
19. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M (1998) Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341(2-3):309-315
20. Bandi N, Kompella UB (2001) Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells. Eur J Pharmacol 425(2):109-116
21. Meliconi R, Pulsatelli L, Dolzani P, Boiardi L, Macchioni P, Salvarani C, Silvestri T, Frizziero L (2000) Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum 43(11):2472-2480
22. Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M, Sasano M, Yoshino S (2000) Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology 39:1255-1262
23. Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY (2001) Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19(3):321-324
24. Strunk J, Lange U, Kürten B, Schmidt KL, Neeck G (2003) Doppler sonographic findings in the long bicipital tendon sheath in patients with rheumatoid arthritis as compared with patients with degenerative diseases of the shoulder. Arthritis Rheum 48(7):1828-1832
25. Terslev L, Torp-Pedersen S, Savnik A, von der Recke P, Qvistgaard E, Danneskiold-Samsoe B, Bliddal H (2003) Doppler ultrasound and magnetic resonance imaging of synovial inflammation of the hand in rheumatoid arthritis: a comparative study. Arthritis Rheum 48(9):243-241
26. Strunk J, Lange U (2004) Three-dimensional power Doppler sonographic visualization of synovial angiogenesis in rheumatoid arthritis. J Rheumatol 31(5):1004-1006
27. Strunk J, Heinemann E, Schmidt KL, Neeck G, Lange U (2004) A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and serum vascular endothelial growth factor (VEGF) level measurement. Rheumatology 43:1480-1483